...
首页> 外文期刊>Journal of human hypertension >PD.05. The anorexigenic peptides, neuromedin U-25 and neuromedin S, are present in the human cardiovascular system and function as potent vasoconstrictors
【24h】

PD.05. The anorexigenic peptides, neuromedin U-25 and neuromedin S, are present in the human cardiovascular system and function as potent vasoconstrictors

机译:PD.05。厌食肽,神经调节素U-25和神经调节素S,存在于人的心血管系统中,并起有效的血管收缩剂作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Neuromedin U (NMU), shown to elicit a pressor response in rats (Minamino ef ah, 1985), was paired with the 'orphan' G-protein-coupled receptors, NMUl and NMU2 (Howard et ah, 2000). This peptide has an important role in energy regulation; NMU~'~ mice developed obesity (Hanada et al, 2004) and NMU Argl65Trp variant co-segregated with childhood obesity (Hainerova et ah, 2006). Recently, neuromedin S (NMS) was paired with the same receptors and also has pressor (Mori et al., 2005) and anorexigenic actions [Ida et ah, 2005) in rats. However, little is known about direct effects of these peptides on vascular beds and on their vascular effects in humans. Using a novel RIA, NMU-25-LI was detected in human plasma, left ventricle (LV), coronary artery (CA), saphenous vein (SV) and adipose tissue.
机译:已显示在大鼠中引起升压反应的神经调节素U(NMU)(Minamino ef ah,1985)与“孤儿” G蛋白偶联受体NMU1和NMU2配对(Howard等,2000)。该肽在能量调节中具有重要作用。 NMU小鼠发展为肥胖(Hanada等,2004),并且NMU Arg165Trp变体与儿童肥胖共同分离(Hainerova等,2006)。最近,神经调节素S(NMS)与相同的受体配对,并且在大鼠中具有升压作用(Mori等,2005)和厌食作用(Ida等,2005)。然而,关于这些肽对血管床的直接作用及其对人类血管作用的了解很少。使用新型RIA,可在人血浆,左心室(LV),冠状动脉(CA),大隐静脉(SV)和脂肪组织中检测到NMU-25-LI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号